Fig. 5.
Low BSP expression (20%) in a moderate differentiated acinar prostate carcinoma (G2, ISUP 2). Immunohistochemistry BSP.

Low BSP expression (20%) in a moderate differentiated acinar prostate carcinoma (G2, ISUP 2). Immunohistochemistry BSP.

or Create an Account

Close Modal
Close Modal